LDHA and atherosclerosis: In short, the present study indicated that miR-638 could repress the proliferation, migration, invasion abilities and glycolysis of VSMCs by targeting, at least in part, LDHA, which provides a novel potential therapeutic strategy for human vascular diseases, such as atherosclerosis and restenosis.